Nrx Pharmaceuticals Inc (NRXP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.242	-	-	-	-
Cost Of Revenue	0.097	-	-	-	-
Gross Profit	0.145	-	-	-	-
Operating Expenses	11.77% 4.169	3.73	3.847	7.05	5.998
Benefits Costs and Expenses	4.266	-	-	-	-
Costs And Expenses	4.266	-	-	-	-
Depreciation and Amortization	0.026	-	-	-	-
Operating Income/Loss	7.88% -4.024	-3.73	-3.847	-7.05	-5.998
Nonoperating Income/Loss	86.53% -1.866	-13.85	-1.664	-0.847	-0.53
Income/Loss From Continuing Operations Before Tax	77.11% -4.024	-17.58	-5.512	-7.897	-6.528
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	66.50% -5.89	-17.58	-5.512	-7.897	-6.528
Net Income/Loss	66.50% -5.89	-17.58	-5.512	-7.897	-6.528
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	23.96% 22.23	17.93	-0.7579	10.52	8.8523
Basic Earnings Per Share	72.45% -0.27	-0.98	-0.36	-0.75	-0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%